244 related articles for article (PubMed ID: 36512324)
1. Extracellular Vesicle-Packaged circATP2B4 Mediates M2 Macrophage Polarization via miR-532-3p/SREBF1 Axis to Promote Epithelial Ovarian Cancer Metastasis.
Wang F; Niu Y; Chen K; Yuan X; Qin Y; Zheng F; Cui Z; Lu W; Wu Y; Xia D
Cancer Immunol Res; 2023 Feb; 11(2):199-216. PubMed ID: 36512324
[TBL] [Abstract][Full Text] [Related]
2. Extracellular vesicle-packaged miR-181c-5p from epithelial ovarian cancer cells promotes M2 polarization of tumor-associated macrophages via the KAT2B/HOXA10 axis.
Yang S; Zhao H; Xiao W; Shao L; Zhao C; Sun P
J Gene Med; 2022 Oct; 24(10):e3446. PubMed ID: 36027869
[TBL] [Abstract][Full Text] [Related]
3. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
Zhang C; Li Y; Zhao W; Liu G; Yang Q
Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655
[TBL] [Abstract][Full Text] [Related]
4. circFTO from M2 macrophage-derived small extracellular vesicles (sEV) enhances NSCLC malignancy by regulation miR-148a-3pPDK4 axis.
Liu Q; Xu P; Jin M; Wang L; Hu F; Yang Q; Bi R; Xiao H; Jiang L; Ding F
Cancer Immunol Immunother; 2024 Mar; 73(5):91. PubMed ID: 38554157
[TBL] [Abstract][Full Text] [Related]
5. MiR-539-3p promotes the progression of epithelial ovarian cancer by targeting SPARCL1.
Gong YB; Fan XH
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2366-2373. PubMed ID: 30964161
[TBL] [Abstract][Full Text] [Related]
6. Tumor-derived extracellular vesicles containing long noncoding RNA PART1 exert oncogenic effect in hepatocellular carcinoma by polarizing macrophages into M2.
Zhou J; Che J; Xu L; Yang W; Zhou W; Zhou C
Dig Liver Dis; 2022 Apr; 54(4):543-553. PubMed ID: 34497040
[TBL] [Abstract][Full Text] [Related]
7. CircBNC2 affects epithelial ovarian cancer progression through the miR-223-3p/ LARP4 axis.
Lu M; Gong B; Wang Y; Li J
Anticancer Drugs; 2023 Mar; 34(3):384-394. PubMed ID: 36730544
[TBL] [Abstract][Full Text] [Related]
8. RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis.
Wang S; Li Z; Zhu G; Hong L; Hu C; Wang K; Cui K; Hao C
J Ovarian Res; 2021 Nov; 14(1):154. PubMed ID: 34774079
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival.
Fu X; Li Y; Alvero A; Li J; Wu Q; Xiao Q; Peng Y; Hu Y; Li X; Yan W; Guo K; Zhou W; Wang Y; Liu J; Zhang Y; Mor G; Wen J; Yin G
Oncotarget; 2016 Dec; 7(49):80633-80654. PubMed ID: 27811362
[TBL] [Abstract][Full Text] [Related]
10. Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype.
Zhu X; Shen H; Yin X; Yang M; Wei H; Chen Q; Feng F; Liu Y; Xu W; Li Y
J Exp Clin Cancer Res; 2019 Feb; 38(1):81. PubMed ID: 30770776
[TBL] [Abstract][Full Text] [Related]
11. miR-590-3p Promotes Ovarian Cancer Growth and Metastasis via a Novel FOXA2-Versican Pathway.
Salem M; O'Brien JA; Bernaudo S; Shawer H; Ye G; Brkić J; Amleh A; Vanderhyden BC; Refky B; Yang BB; Krylov SN; Peng C
Cancer Res; 2018 Aug; 78(15):4175-4190. PubMed ID: 29748371
[TBL] [Abstract][Full Text] [Related]
12. CircEXOC6B Suppresses the Proliferation and Motility and Sensitizes Ovarian Cancer Cells to Paclitaxel Through miR-376c-3p/FOXO3 Axis.
Zheng Y; Li Z; Yang S; Wang Y; Luan Z
Cancer Biother Radiopharm; 2022 Nov; 37(9):802-814. PubMed ID: 33006481
[No Abstract] [Full Text] [Related]
13. Exosomes derived from hypoxic epithelial ovarian cancer cells deliver microRNAs to macrophages and elicit a tumor-promoted phenotype.
Chen X; Zhou J; Li X; Wang X; Lin Y; Wang X
Cancer Lett; 2018 Oct; 435():80-91. PubMed ID: 30098399
[TBL] [Abstract][Full Text] [Related]
14. CircCERS6 Suppresses the Development of Epithelial Ovarian Cancer Through Mediating miR-630/RASSF8.
Li X; Jiang X; Lu J; Lin Y; Jiang L; Li Y; Wan F; Wang C
Biochem Genet; 2022 Dec; 60(6):2611-2629. PubMed ID: 35676548
[TBL] [Abstract][Full Text] [Related]
15. Extracellular vesicle-mediated delivery of miR-127-3p inhibits the proliferation and invasion of choriocarcinoma cells by targeting ITGA6.
Ma H; Weng F; Wang L; Tong X; Yao Y; Li H
Exp Cell Res; 2022 May; 414(2):113098. PubMed ID: 35288170
[TBL] [Abstract][Full Text] [Related]
16. M2 macrophage-derived extracellular vesicles promote gastric cancer progression via a microRNA-130b-3p/MLL3/GRHL2 signaling cascade.
Zhang Y; Meng W; Yue P; Li X
J Exp Clin Cancer Res; 2020 Jul; 39(1):134. PubMed ID: 32660626
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA MAGI1-IT1 promoted invasion and metastasis of epithelial ovarian cancer via the miR-200a/ZEB axis.
Gao H; Li X; Zhan G; Zhu Y; Yu J; Wang J; Li L; Wu W; Liu N; Guo X
Cell Cycle; 2019 Jun; 18(12):1393-1406. PubMed ID: 31122127
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA RHPN1-AS1 promotes tumorigenesis and metastasis of ovarian cancer by acting as a ceRNA against miR-596 and upregulating LETM1.
Wang J; Ding W; Xu Y; Tao E; Mo M; Xu W; Cai X; Chen X; Yuan J; Wu X
Aging (Albany NY); 2020 Mar; 12(5):4558-4572. PubMed ID: 32163372
[TBL] [Abstract][Full Text] [Related]
19. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
Zhang Y; Dun Y; Zhou S; Huang XH
Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
[TBL] [Abstract][Full Text] [Related]
20. LINC01133 contribute to epithelial ovarian cancer metastasis by regulating miR-495-3p/TPD52 axis.
Liu S; Xi X
Biochem Biophys Res Commun; 2020 Dec; 533(4):1088-1094. PubMed ID: 33036757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
